Name: How Medicines are Born: The Imperfect Science of Drugs (en Inglés)
Price: 1590.72 MXN
Availability: InStock
Author: Lisa Vozza; Maurizio D'incalci
ISBN: 9781786342973

Envío gratis

portada How Medicines are Born: The Imperfect Science of Drugs (en Inglés)

Formato

Libro Físico

Editorial

Wspc

Autor

Lisa Vozza; Maurizio D'incalci

Año

2017

Idioma

Inglés

N° páginas

186

Encuadernación

Tapa Dura

ISBN13

9781786342973

N° edición

How Medicines are Born: The Imperfect Science of Drugs (en Inglés)

Lisa Vozza; Maurizio D'incalci (Autor) · Wspc · Tapa Dura

Libro Nuevo

$ 1,590.72

$ 2,892.23

Ahorras: $ 1,301.50

45% descuento

Envío normal

Origen: España (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 18 de Julio y el Viernes 26 de Julio.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "How Medicines are Born: The Imperfect Science of Drugs (en Inglés)"

This book is an excursion into the drug development process, from the initial conception in a chemical or molecular biology lab, via tests in isolated cells and animals, to the stage of clinical trials. The human body is a complex ecosystem where little is conclusively known in terms of its response to medication, for both sick and healthy individuals. The considerable degree of uncertainty inherent in health-related research can lead to approval of controversial medicines, particularly in high-stakes scenarios and medical crises. Real-life examples are drawn on here to explain the decision making processes behind the acceptance of new drugs, disproving misconceptions around medicines by delving into the history and current practice of the drug development process.Originally written in Italian, How Medicines are Born helps patients, students, public health officials physicians, healthcare practitioners and biomedical scientists make informed decisions on the benefits and disadvantages of select medicine based on an understanding of the history of drug development.